Insulet Corp at Wells Fargo Healthcare Conference Transcript

Sep 09, 2022 / 12:00PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

(technical difficulty) analyst at Wells Fargo. And it is my pleasure to host this session with Insulet.

With us, we have Wayde McMillan, the CFO. I'm a little winded from just running. And Deb Gordon, the Head of Investor Relations. The format is going to be a fireside chat. (Operator Instructions)

And so Wayde and Deb, thank you so much for being here.

Wayde D. McMillan - Insulet Corporation - Executive VP,CFO & Treasurer

Good morning. Good morning, everybody. Thanks for having us, Larry. Great venue here.

Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

Thank you.

Wayde D. McMillan - Insulet Corporation - Executive VP,CFO & Treasurer

Nice to be back in person.

Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot